再问科研
基金查询
学科分析
选题分析
AI润色(Beta)
新闻公告
趋势报告
经验分享
登录
注册
吴孔明
面上项目
项目编号:
81874120 【年份:2018】
项目名称:
DACH1与EGFR-STAT3信号的交互作用调控三阴性乳腺癌恶性生物学行为
资助金额:
57万
单位名称:
华中科技大学
学科分类:
H1819.肿瘤生物治疗
参与者:
华中科技大学
DACH1与EGFR-STAT3信号的交互作用调控三阴性乳腺癌恶性生物学行为
项目批准号:
81874120
批准年份:
2018
学科分类:
H1819.肿瘤生物治疗
项目负责人:
吴孔明
资助类别:
面上项目
负责人职称:
教授
依托单位:
华中科技大学
资助金额:
57万元
关键词:
STAT3;肿瘤干细胞;表皮生长因子受体;乳腺肿瘤;上皮-间质转换
起止时间:
2019-01-01到2022-12-31
中英文摘要
结题摘要
结题报告
项目成果
项目参与人
查看更多信息请先登录或注册
查看更多信息请先登录或注册
查看更多信息请先登录或注册
标题
类型
全部
期刊论文
会议论文
著作
奖励
专利
作者
搜索
重置
序号
标题
类型
作者
1
CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers
期刊论文
Jiao Y;Yi M;Xu L;Ch Q;Yan Y;Luo S;Wu K
2
The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-βand PD-L1
期刊论文
Yi M;Zhang J;Niu M;Yan Y;Jiao Y;Luo S;Zhou P;Wu K
3
MiRNA-mediated EMT and CSCs in cancer
期刊论文
Dong B;Li S;Zhu S;Yi M;Luo S;Wu K
4
Organoid technology and applications in cancer research
期刊论文
Xu H;Lyu X;Yi M;Zhao W;Song Y;Wu K
5
EYA2 Correlates with Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival
期刊论文
Xu H;Jiao Y;Yi M;Zhao W;Wu K
6
Biological characteristics and clinical significance of soluble PD-1/PD-L1 and exosomal PD-L1 in cancer
期刊论文
Niu M;Liu Y;Yi M;Jiao D;Wu K
7
Next Generation Chimeric Antigen Receptor T Cells: Toxicities and Safety Strategies
期刊论文
Yu S;Yi M;Qin S;Wu K
8
Distinct Roles of VEGFA and ANGPT2 in Lung Adenocarcinoma and Squamous Cell Carcinoma
期刊论文
Qin S;Yi M;Jiao D;Li A;Wu K
9
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
期刊论文
Niu M;Yi M;Luo S;Wu K
10
Prognostic values of TIM-3 expression in patients with solid tumors: a meta-analysis and database evaluation
期刊论文
Qin S;Dong B;Yi M;Chu Q;Wu K
11
Roles of tumor-associated macrophages in tumor progression:implication on therapeutic strategies
期刊论文
Zhu S;Yi M;Wu Y;Dong B;Wu K
12
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
期刊论文
Wu Y;Yi M;Niu M;Mei Q;Wu K
13
Tumor organoids: Applications in cancer modeling and potentials in precision medicine
期刊论文
Xu H;Jiao D;Liu A;Wu K
14
The roles of exosomes in cancer drug resistance and its therapeutic application
期刊论文
Li S;Yi M;Dong B;Jiao Y;Luo S;Wu K
15
NRF2-Driven KEAP1 Transcription in Human Lung Cancer
期刊论文
Tian Y;Liu Q;Yu S;Ch Q;Chen Y;Wu K;Wang L
16
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma
期刊论文
Yi M;Li A;Zhou L;Chu Q;Luo S;Wu K
17
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
期刊论文
Yi M;Niu M;Wu Y;Ge H;Jiao D;Zhu S;Zhang J;Yan Y;Zhou P;Chu Q;Wu K
18
Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
期刊论文
Li A;Yi M;Qin S;Song Y;Chu Q;Wu K
19
CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer
期刊论文
Yu S;Yi M;Xu L;Qin S;Li A;Wu K
20
The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017
期刊论文
Yi M;Li A;Zhou L;Chu Q;Song Y;Wu K
21
Advances of targeted therapy for hepatocellular carcinoma
期刊论文
Niu M;Yi M;Li N;Wu KJ;Wu K
22
Dachshund depletion disrupts mammary gland development and diverts the composition of the mammary gland progenitor pool
期刊论文
Jiao X;Li Z;Wang M;Katiyar S;Di Sante G;Farshchian M;Andrew P;South AP;Mardon G;Cocola C;Colombo D;Reinbold R;Zucchi I;Wu K;Tabas I;Spike BT;Pestell RG
23
CD44 as a tumor biomarker and therapeutic target
期刊论文
Xu H;Niu M;Yuan X;Wu K;Liu A
24
SIX1 Activates STAT3 Signaling to Promote the Proliferation of Thyroid Carcinoma via EYA1
期刊论文
Kong D;Li A;Liu Y;Cui Q;Wang K;Zhang D;Tang J;Du Y;Liu Z;Wu G;Wu K
25
Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple- negative breast cancer
期刊论文
Yi M;Wu Y;Niu M;Zhu S;Zhang J;Yan Y;Zhu P;Dai Z;Wu K
26
Roles of Microvesicles in Tumor Progression and Clinical Applications
期刊论文
Zhu S;Li S;Yi M;Li N;Wu K
27
Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis
期刊论文
Yi M;Li T;Qin S;Chu Q;Li A;Wu K
28
Blocking TGF-β signaling to enhance the efficacy of immune checkpoint inhibitor
期刊论文
Bai X;Yi M;Jiao Y;Chu Q;Wu K
29
Prospects for combining immune checkpoint blockade with PARP inhibition
期刊论文
Li A;Yi M;Qin S;Song Y;Chu Q;Luo S;Wu K
30
Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers
期刊论文
Yi M;Niu M;Zhang J;Li S;Zhu S;Yan Y;Li N;Zhou P;Wu K
31
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
期刊论文
Qin S;Li A;Yi M;Yu S;Zhnag M;Wu K
32
Manipulating gut microbiota composition to enhance the therapeutic effect of cancer immunotherapy
期刊论文
Yi M;Jiao D;Qin S;Chu Q;Li A;Wu K
33
The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis
期刊论文
Wu K;Yi M;Qin S;Chu Q;Zheng X;Wu K
34
Advances and perspectives of PARP inhibitors
期刊论文
Yi M;Dong B;Qin S;Chu Q;Wu K;Luo S
35
Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
期刊论文
Yan Y;Huang L;Liu Y;Yi M;Chu Q;Jiao D;Wu K
36
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
期刊论文
Yi M;Jiao D;Qin S;Chu Q;Wu K;Li A
37
Immune pressures drive the promoter hypermethylation of neoantigen genes
期刊论文
Yi M;Dong B;Chu Q;Wu K
38
Recent advances and challenges of bispecific antibodies in solid tumors
期刊论文
Wu Y;Yi M;Zhu S;Wang H;Wu K
39
The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction
期刊论文
Li S;Yi M;Dong B;Tian X;Luo S;Wu K
40
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
期刊论文
Yi M;Zheng X;Niu M;Zhu S;Ge H;Wu K
41
Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA
期刊论文
Bai X;Yi M;Xia X;Yu S;Zheng X;Wu K
42
RDGN-based predictive model for the prognosis of breast cancer
期刊论文
Dong B;Yi M;Luo S;Li A;Wu K
43
Regulation of PD-L1 expression in the tumor microenvironment
期刊论文
Yi M;Niu M;Xu L;Luo S;Wu K
44
Global burden and trend of acute lymphoblastic leukemia from 1990 to 2017
期刊论文
Yi M;Zhou L;Li A;Luo S;Wu K
45
Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study
期刊论文
Yi M;Li T;Niu M;Luo S;Chu Q;Wu K
46
Upregulation of STAT1-CCL5 axis is a biomarker of colon cancer and promotes the proliferation of colon cancer cells
期刊论文
Niu M;Yi M;Dong B;Luo S;Wu K
47
The role of cancer-derived microRNAs in cancer immune escape
期刊论文
Yi M;Xu L;Jiao Y;Luo S;Li A;Wu K
48
The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017
期刊论文
Bai X;Yi M;Dong B;Zheng X;Wu K
49
Prognostic significance of KRT19 in lung squamous cancer
期刊论文
Yuan X;Yi M;Dong B;Ch Q;Wu K
50
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
期刊论文
Qin S;Xu L;Yi M;YU S;Wu K;Luo S
51
A Novel Asymmetrical Anti-HER2/CD3 Bispecific Antibody Exhibits Potent Cytotoxicity for HER2-positive Tumor Cells
期刊论文
Yu S;Zhang J;Yan Y;Yao X;Fang L;Xiong H;Liu Y;Chu Q;Zhou P;Wu K
查看更多信息请先登录或注册
相关项目
1
M1病毒通过nsP2下调肿瘤相关超级增强子活性因子RPB1蛋白抗骨肉瘤作用的机制研究
2
靶向抑制干扰素调节因子IRF4增强CAR-T细胞抗肿瘤疗效的作用及机制研究
3
泛素特异性蛋白酶1抑制剂ML323对非小细胞肺癌免疫微环境的激活及对CD318 CAR-T细胞的增效作用研究
趋势报告
国自然申请攻略干货全集(1月30日大更新)
【专业会员】独享&免费内容合集
2023年国自然二级学科资助率汇总
经验分享
国自然申请攻略干货全集(1月30日大更新)
【专业会员】独享&免费内容合集
2023年国自然二级学科资助率汇总
年份:
请选择
2022年
2021年
2020年
2019年
2018年
2017年
2016年
2015年
2014年
2013年
2012年
2011年
2010年
2009年
2008年
2007年
2006年
2005年
2004年
2003年
2002年
2001年
2000年
1999年
1998年
1997年
1996年
1995年
1994年
1993年
1992年
1991年
1990年
1989年
1988年
项目负责人:
单位名称:
提交
由于2020年国自然政策发生变化,若您身边有2020年获得过国自然的请提交一下